Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dose is very low. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately for further instructions.
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Deflazacort (moderarte)
Live attenuated vaccines and related products (severe)
Zidovudine (severe)
Adalimumab (severe)
Clozapine (severe)
This medicine is used to relieve signs and symptoms including pain and swelling associated with rheumatoid arthritis in adult patients. It is also effective in reducing structural damages and improving physical functions in adult patients with moderate to severe rheumatoid arthritis.
This medicine is used to relieve signs and symptoms such as pain, swelling, the formation of scales on the skin, etc. associated with psoriatic arthritis in adults. It also reduces structural damages and improves physical functions in adults with psoriatic arthritis.
This medicine is used for the treatment of moderate to severe chronic plaque psoriasis when systemic therapy or phototherapy can be used and the use of other medicines is inappropriate or less appropriate.
This medicine is used to signs and symptoms such as pain, swelling, diarrhea, weight loss, fever, etc. associated with Crohn's disease in adults and children above 6 years of age. It is normally used when other medicines are not able to provide symptomatic relief or are not well tolerated.
This medicine is used to relieve signs and symptoms such as pain, swelling, sores in the lining of the colon and rectum, etc. associated with ulcerative colitis in adults. It is generally used when other medicines are ineffective or are not well tolerated.
This medicine is used to relieve pain, swelling, and structural damage associated with ankylosing spondylitis, a chronic inflammatory condition of the vertebral column in adults.
Infections (severe)
Decrease in blood cell count (severe)
Headache
Depression (severe)
Dizziness
Heart Rhythm disorders (severe)
Nausea
Abdominal pain
Skin Reactions
Injection site reactions (severe)
This medicine is not recommended for use in patients with a known allergy to REMICADE 100mg Infusion Vial (Infliximab) ^ , any murine proteins, or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients suffering from active, severe infections due to the increased risk of worsening of the patient's condition.